weight-loss drugs
Scope
Date
~
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Tech, Media & Telecom
LG Electronics names strategy chief as new CEO
South Korea's LG Electronics Inc. on Thursday appointed its strategy chief Cho Joo-wan as the company's new chief executive officer, in a major resh...
Nov 26, 2021 (Gmt+09:00)
-
Markets
Koreans log $5.7 bn loss in Q3 from overseas stock investments
South Korean investors suffered a $5.7 billion loss in the third quarter from overseas stock investments on weak foreign shares. Individual investor...
Nov 18, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
Batteries
LG Group's No. 2 exec Kwon to head EV battery unit
Kwon Young-soo, the No. 2 leader of South Korea's LG Group, will be appointed as the chief executive officer of LG Energy Solution Ltd. next month, ...
Oct 25, 2021 (Gmt+09:00)
-
Airlines
Kumho Asiana assures 30-year profits to Gate Gourmet in catering deal
Kumho Asiana Group’s management assured net profits for 30 years to Gate Gourmet when the South Korean conglomerate signed a deal for Asiana A...
Oct 12, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
Apple Likely Has More App Store Deals to Make
As Apple Inc. works to negotiate its way out of its App Store troubles, one thing is becoming increasingly clear: the technology titan mig...
Sep 08, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Aerospace & Defense
Kolon enters private space business with composite materials
Kolon will be the next major South Korean business group to join the race in the fast-growing space sector by developing and making light composite ...
Aug 27, 2021 (Gmt+09:00)
language -
Retail
Japan’s Aeon plans to sell off struggling Ministop Korea
South Korea’s fifth-largest convenience store chain Ministop Korea Co. is up for sale by its owner, the Aeon Group of Japan. Ministop Korea is...
Aug 23, 2021 (Gmt+09:00)
-
IPOs
Can SSG.COM IPO succeed despite mounting losses?
SSG.COM, the e-commerce brand of South Korea’s retail giant Shinsegae Inc., reported its second-largest operating loss in the second quarter a...
Aug 20, 2021 (Gmt+09:00)
-
Earnings
Coupang’s revenue grows by more than 50% for 15 consecutive quarters
The US-listed e-commerce giant Coupang Inc. has posted its highest-ever quarterly revenue. The company reported on Aug. 12 that its second-quarter r...
Aug 12, 2021 (Gmt+09:00)
language -
Alternative investments
Tourism, aircraft take bulk of 2020 alternatives loss
South Korea's eight leading brokerage companies, including Mirae Asset Securities Co. and Hana Financial Investment Co., are estimated to have booke...
Aug 05, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Earnings
SK Hynix sees robust chip demand for rest of year after strong Q2 sales
SK Hynix Inc., the world’s second-largest memory chipmaker, on Tuesday posted its highest quarterly profit and sales in nearly three years on ...
Jul 27, 2021 (Gmt+09:00)
-
Underwater cables
LS Cable to build Korea’s tallest cable production tower, invest $161 million
LS Cable & System Ltd. is investing 185.9 billion won ($161 million) to expand its high-voltage underwater cable manufacturing facilities, inclu...
Jul 26, 2021 (Gmt+09:00)
-
Earnings
Korea Shipbuilding delivers dismal Q2 loss on higher steel plate prices
Korea Shipbuilding & Offshore Engineering Co. (KSOE), a leading South Korean shipbuilder, on Wednesday posted a dismal quarterly operating loss ...
Jul 21, 2021 (Gmt+09:00)
language -
Entertainment
Disney Plus' S.Korea launch delayed after Netflix's court loss
Disney Plus, a global over-the-top (OTT) streaming service provider, has pushed back its South Korean service launch by about a quarter to the end o...
Jul 20, 2021 (Gmt+09:00)
-
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language -
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
Mezzanine loans
Mirae, NH face lawsuit over Drew Las Vegas loan loss
Mirae Asset Securities Co. and NH Investment & Securities Co. have been sued by South Korean institutional investors over the loss of their comb...
Jun 01, 2021 (Gmt+09:00)
-
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
Venture capital
Vision Fund loss slashes Masayoshi Son’s 2020 salary by 52%
SoftBank Group founder and CEO Masayoshi Son’s salary more than halved last year, according to the group’s regulatory filing on May 28.T...
May 28, 2021 (Gmt+09:00)
-
Korean chipmakers
Samsung, TSMC up ante in US foundry competition
The world’s two largest foundry chipmakers, Taiwan Semiconductor Manufacturing Co. (TSMC) and Samsung Electronics Co., are upping the ante in ...
May 24, 2021 (Gmt+09:00)
language -
Mezzanine loans
Korean LPs to sue Mirae, NH over Las Vegas loan loss
South Korean institutional investors in the Drew Las Vegas development are preparing to file a lawsuit against two domestic brokerage firms, seeking...
May 13, 2021 (Gmt+09:00)